Stockreport

Ono Pharmaceutical (TSE:4528) Valuation Check As New Neurology And Rare Disease Partnerships Advance [Yahoo! Finance]

ONO PHARM CO UNSP/ADR  (OPHLY) 
NASDAQ:AMEX Investor Relations: ono.co.jp/eng/investor/index.html
PDF Ono Pharmaceutical (TSE:4528) is back in focus after expanding its collaboration with Congruence Therapeutics into neurology and immunology, alongside a fresh target di [Read more]